CD8+ Tumour-Infiltrating Lymphocytes and Tumour Microenvironment Immune Types as Biomarkers for Immunotherapy in Sinonasal Intestinal-Type Adenocarcinoma
Open Access
- 28 April 2020
- Vol. 8 (2), 202
- https://doi.org/10.3390/vaccines8020202
Abstract
Background. Intestinal-type adenocarcinoma (ITAC) is a rare tumour occurring in the ethmoid sinus. Recent years have brought advances in endoscopic surgery and precision radiotherapy; however, five-year overall survival has not improved and remains at 35–80%, depending on tumour stage and histology. Therefore, there is a need for new therapeutic options. Methods. We evaluated CD8+ tumour-infiltrating lymphocytes (TILs) and tumour microenvironment immune type (TMIT, combining CD8+ TILs and PD-L1) as predictive biomarkers for immunotherapy in a series of 133 ITAC. All results were correlated to clinical and follow-up data. Results. The presence of intratumoural CD8+ TILs was low in 57% of cases and high in 8% of cases. Tumoural PD-L1 positivity was observed in 26% of cases. CD8+ TILs and TMIT correlated with the histological subtype of ITAC and with better overall survival. The presence of stromal PD-L1-positive macrophages was related to intratumoural CD8+ TILs. PD-L1 expression on tumour cells or macrophages did not show prognostic value. Conclusions. TMIT classification did not have additional prognostic value over CD8+ TILs alone. The modest percentage of CD8high/PD-L1pos cases indicates that ITAC is a lowly immunogenic tumour type. Nevertheless, a proportion of ITAC, especially the papillary and colonic subtypes, could benefit from therapy with immune checkpoint inhibitors.This publication has 39 references indexed in Scilit:
- Sinonasal carcinoma: clinical, pathological, genetic and therapeutic advancesNature Reviews Clinical Oncology, 2014
- International comparisons of the incidence and mortality of sinonasal cancerCancer Epidemiology, 2013
- Multicenter Study to Assess Endoscopic Resection of 159 Sinonasal AdenocarcinomasAnnals of Surgical Oncology, 2013
- Sinonasal adenocarcinoma: A 16‐year experience at a single institutionHead & Neck, 2013
- MacrophagesOncoImmunology, 2013
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune EscapeScience Translational Medicine, 2012
- The blockade of immune checkpoints in cancer immunotherapyNature Reviews Cancer, 2012
- Anterior craniofacial resection for malignant paranasal tumors: A monoinstitutional experience of 366 casesHead & Neck, 2011
- Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigmNature Immunology, 2010
- Adenocarcinoma of Ethmoid: A GETTEC Retrospective Multicenter Study of 418 CasesThe Laryngoscope, 2008